血小板裂解液治疗骨关节炎:临床前和临床研究的系统回顾。

Q1 Medicine
MUSCULOSKELETAL SURGERY Pub Date : 2024-09-01 Epub Date: 2024-06-03 DOI:10.1007/s12306-024-00827-z
K Valtetsiotis, A Di Martino, M Brunello, C D'Agostino, R Poluzzi, R Ferri, P Mora, F Traina, C Faldini
{"title":"血小板裂解液治疗骨关节炎:临床前和临床研究的系统回顾。","authors":"K Valtetsiotis, A Di Martino, M Brunello, C D'Agostino, R Poluzzi, R Ferri, P Mora, F Traina, C Faldini","doi":"10.1007/s12306-024-00827-z","DOIUrl":null,"url":null,"abstract":"<p><p>Intra-articular injection-based therapy is often used aside conservative treatment and lifestyle modifications to manage knee osteoarthritis (KO) patients. Conventional injections contain steroids and hyaluronic acid, while more recently multipotential adult stem cell, platelet-rich plasma (PRP), and platelet lysate (PL) injections have been used to promote cartilage regeneration or repair. The aim of the current study is to analyse current evidence on PL injections for the treatment of KO and to determine if these are effective and how these perform compared to other injection regimens. The databases of Scopus, Embase, PubMed, Web of Science, and Cochrane Library were searched on 30 June 2023. Risk of bias was assessed using the SYRCLE tool for animal studies and Cochrane RoB 2 as well as ROBINS-I tool for human studies. Studies were included if these were in English, any year, and regarded animals with osteoarthritis (OA) or human adult patients with OA. In vitro trials and non-adult human studies were excluded. Results on OA symptom stage and severity, and pain were recorded. The research retrieved three human studies (n = 48, n = 25, n = 58) and four animal studies: one rabbit, two studies, and one rat study. PL was found to decrease KO symptoms at follow-up ≤ 1 year with respect to baseline levels and when compared to hyaluronic acid or platelet-rich plasma. Symptoms returned 6 months-1 year after the final administration, with studies showing peak efficacy at approximately 6 months. Animal studies showed clinical improvements, reduction of lameness, and partial effect on the cartilage regeneration of the seven studies, two had a high risk of bias, four were associated to some concerns, and one had low risk. A major source of bias in these studies was the use of questionnaires and scoring that could be subject to interpretation. Overall, PL was well-tolerated and showed efficacy comparable to PRP; when pain control was assessed, it showed similar efficacy compared to hyaluronic acid. These findings may support its use in clinical trials to confirm these initial findings; future research should also focus on the comparison with other non-surgical treatments, on a more detail of the potential regenerative properties, and to optimise the treatment schedule.</p>","PeriodicalId":18875,"journal":{"name":"MUSCULOSKELETAL SURGERY","volume":" ","pages":"275-288"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11371856/pdf/","citationCount":"0","resultStr":"{\"title\":\"Platelet lysate for the treatment of osteoarthritis: a systematic review of preclinical and clinical studies.\",\"authors\":\"K Valtetsiotis, A Di Martino, M Brunello, C D'Agostino, R Poluzzi, R Ferri, P Mora, F Traina, C Faldini\",\"doi\":\"10.1007/s12306-024-00827-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Intra-articular injection-based therapy is often used aside conservative treatment and lifestyle modifications to manage knee osteoarthritis (KO) patients. Conventional injections contain steroids and hyaluronic acid, while more recently multipotential adult stem cell, platelet-rich plasma (PRP), and platelet lysate (PL) injections have been used to promote cartilage regeneration or repair. The aim of the current study is to analyse current evidence on PL injections for the treatment of KO and to determine if these are effective and how these perform compared to other injection regimens. The databases of Scopus, Embase, PubMed, Web of Science, and Cochrane Library were searched on 30 June 2023. Risk of bias was assessed using the SYRCLE tool for animal studies and Cochrane RoB 2 as well as ROBINS-I tool for human studies. Studies were included if these were in English, any year, and regarded animals with osteoarthritis (OA) or human adult patients with OA. In vitro trials and non-adult human studies were excluded. Results on OA symptom stage and severity, and pain were recorded. The research retrieved three human studies (n = 48, n = 25, n = 58) and four animal studies: one rabbit, two studies, and one rat study. PL was found to decrease KO symptoms at follow-up ≤ 1 year with respect to baseline levels and when compared to hyaluronic acid or platelet-rich plasma. Symptoms returned 6 months-1 year after the final administration, with studies showing peak efficacy at approximately 6 months. Animal studies showed clinical improvements, reduction of lameness, and partial effect on the cartilage regeneration of the seven studies, two had a high risk of bias, four were associated to some concerns, and one had low risk. A major source of bias in these studies was the use of questionnaires and scoring that could be subject to interpretation. Overall, PL was well-tolerated and showed efficacy comparable to PRP; when pain control was assessed, it showed similar efficacy compared to hyaluronic acid. These findings may support its use in clinical trials to confirm these initial findings; future research should also focus on the comparison with other non-surgical treatments, on a more detail of the potential regenerative properties, and to optimise the treatment schedule.</p>\",\"PeriodicalId\":18875,\"journal\":{\"name\":\"MUSCULOSKELETAL SURGERY\",\"volume\":\" \",\"pages\":\"275-288\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11371856/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MUSCULOSKELETAL SURGERY\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s12306-024-00827-z\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MUSCULOSKELETAL SURGERY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12306-024-00827-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

膝关节骨性关节炎(KO)患者在接受保守治疗和调整生活方式的同时,通常还采用关节内注射疗法。传统的注射疗法包含类固醇和透明质酸,而最近的多潜能成人干细胞、富血小板血浆(PRP)和血小板裂解液(PL)注射疗法则被用于促进软骨再生或修复。本研究的目的是分析目前有关血小板注射治疗KO的证据,并确定这些疗法是否有效,以及与其他注射疗法相比效果如何。本研究于 2023 年 6 月 30 日对 Scopus、Embase、PubMed、Web of Science 和 Cochrane Library 等数据库进行了检索。使用 SYRCLE 工具评估动物研究的偏倚风险,使用 Cochrane RoB 2 和 ROBINS-I 工具评估人类研究的偏倚风险。纳入的研究必须是英文的、任何年份的、针对患有骨关节炎(OA)的动物或患有 OA 的人类成年患者。体外试验和非成人人体研究除外。研究记录了有关 OA 症状阶段和严重程度以及疼痛的结果。研究检索了三项人类研究(n = 48、n = 25、n = 58)和四项动物研究:一项兔子研究、两项研究和一项大鼠研究。研究发现,与玻尿酸或富血小板血浆相比,PL 在随访≤1 年时可减轻 KO 症状的基线水平。最后一次给药后 6 个月至 1 年,症状又会恢复,研究显示约 6 个月时疗效达到顶峰。动物研究显示,临床症状有所改善,跛足症状有所减轻,对软骨再生有部分影响。这些研究存在偏倚的一个主要原因是使用的问卷和评分可能会受到解释的影响。总体而言,PL的耐受性良好,疗效与PRP相当;在评估疼痛控制时,其疗效与透明质酸相似。这些研究结果可能会支持将 PL 用于临床试验,以证实这些初步研究结果;未来的研究还应侧重于与其他非手术疗法的比较、更详细地了解潜在的再生特性以及优化治疗计划。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Platelet lysate for the treatment of osteoarthritis: a systematic review of preclinical and clinical studies.

Intra-articular injection-based therapy is often used aside conservative treatment and lifestyle modifications to manage knee osteoarthritis (KO) patients. Conventional injections contain steroids and hyaluronic acid, while more recently multipotential adult stem cell, platelet-rich plasma (PRP), and platelet lysate (PL) injections have been used to promote cartilage regeneration or repair. The aim of the current study is to analyse current evidence on PL injections for the treatment of KO and to determine if these are effective and how these perform compared to other injection regimens. The databases of Scopus, Embase, PubMed, Web of Science, and Cochrane Library were searched on 30 June 2023. Risk of bias was assessed using the SYRCLE tool for animal studies and Cochrane RoB 2 as well as ROBINS-I tool for human studies. Studies were included if these were in English, any year, and regarded animals with osteoarthritis (OA) or human adult patients with OA. In vitro trials and non-adult human studies were excluded. Results on OA symptom stage and severity, and pain were recorded. The research retrieved three human studies (n = 48, n = 25, n = 58) and four animal studies: one rabbit, two studies, and one rat study. PL was found to decrease KO symptoms at follow-up ≤ 1 year with respect to baseline levels and when compared to hyaluronic acid or platelet-rich plasma. Symptoms returned 6 months-1 year after the final administration, with studies showing peak efficacy at approximately 6 months. Animal studies showed clinical improvements, reduction of lameness, and partial effect on the cartilage regeneration of the seven studies, two had a high risk of bias, four were associated to some concerns, and one had low risk. A major source of bias in these studies was the use of questionnaires and scoring that could be subject to interpretation. Overall, PL was well-tolerated and showed efficacy comparable to PRP; when pain control was assessed, it showed similar efficacy compared to hyaluronic acid. These findings may support its use in clinical trials to confirm these initial findings; future research should also focus on the comparison with other non-surgical treatments, on a more detail of the potential regenerative properties, and to optimise the treatment schedule.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
MUSCULOSKELETAL SURGERY
MUSCULOSKELETAL SURGERY Medicine-Surgery
CiteScore
4.50
自引率
0.00%
发文量
35
期刊介绍: Musculoskeletal Surgery – Formerly La Chirurgia degli Organi di Movimento, founded in 1917 at the Istituto Ortopedico Rizzoli, is a peer-reviewed journal published three times a year. The journal provides up-to-date information to clinicians and scientists through the publication of original papers, reviews, case reports, and brief communications dealing with the pathogenesis and treatment of orthopaedic conditions.An electronic version is also available at http://www.springerlink.com.The journal is open for publication of supplements and for publishing abstracts of scientific meetings; conditions can be obtained from the Editors-in-Chief or the Publisher.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信